10. Quetiapine in Bipolar Disorder

  1. Hagop S. Akiskal4 and
  2. Mauricio Tohen5
  1. Mauricio Kunz1,
  2. Svante Nyberg2 and
  3. Lakshmi N. Yatham3

Published Online: 13 APR 2011

DOI: 10.1002/9780470975114.ch10

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

How to Cite

Kunz, M., Nyberg, S. and Yatham, L. N. (2011) Quetiapine in Bipolar Disorder, in Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition (eds H. S. Akiskal and M. Tohen), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470975114.ch10

Editor Information

  1. 4

    International Mood Center, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0603, USA

  2. 5

    Department of Psychiatry, Division of Mood and Anxiety Disorders, University of Texas Health Science Centre at San Antonio, 7730 Floyd Curl Drive, San Antonio, TX 78229, USA

Author Information

  1. 1

    Department of Psychiatry, Mood Disorders Centre, University of British Columbia, Vancouver, Canada

  2. 2

    Neuroscience TA, AstraZeneca R&D, Södertälje, Sweden

  3. 3

    UBC Department of Psychiatry, UBC Hospital, The University of British Columbia, 2255 Wesbrook Mall, Vancouver BC V6T2AI, Canada

Publication History

  1. Published Online: 13 APR 2011
  2. Published Print: 15 APR 2011

ISBN Information

Print ISBN: 9780470747216

Online ISBN: 9780470975114

SEARCH

Keywords:

  • Quetiapine in Bipolar Disorder;
  • US Food and Drug Administration (FDA);
  • Pharmacology;
  • Montgomery-Asberg Depression Rating Scale (MADRS);
  • Safety and Tolerability of Quetiapine

Summary

This chapter contains sections titled:

  • Introduction

  • Pharmacology

  • Quetiapine in the treatment of acute mania

  • Quetiapine in the treatment of acute bipolar depression

  • Quetiapine in the maintenance treatment of bipolar disorder

  • Safety and tolerability of quetiapine

  • Summary

  • References